Huaxing Shen

发表

Spleen Tyrosine Kinase (SYK) Inhibitor PRT062607 Protects Against Ovariectomy-Induced Bone Loss and Breast Cancer-Induced Bone Destruction.

G. Yao, G. Yuan, H. Feng, 2021, Biochemical pharmacology.

A robust protein-peptide co-assembling nanoformulation (PePCAN) platform with significant cell-entry characteristics for targeted cancer therapy

Xiang Li, F. Sharopov, Kai Liu, 2022, Chemical Engineering Journal.

Design, synthesis, and anti-tumor activities of novel Brevinin-1BYa peptidomimetics.

Honggang Hu, Huaxing Shen, Wei Cong, 2021, Bioorganic & medicinal chemistry letters.

Treatment with Mesenchymal Stem Cell‐Derived Nanovesicle‐Containing Gelatin Methacryloyl Hydrogels Alleviates Osteoarthritis by Modulating Chondrogenesis and Macrophage Polarization

Jiacan Su, Meng Li, Jie Gao, 2023, Advanced healthcare materials.

The recent progress of peptide regulators for the Wnt/β-catenin signaling pathway

N. Zhang, Yuanchun Chen, Honggang Hu, 2023, Frontiers in medicine.

Discovery of an orally effective double-stapled peptide for reducing ovariectomy-induced bone loss in mice

Xiang Li, Mengjun Zheng, Si Chen, 2023, Acta pharmaceutica Sinica. B.

Benzyl stapled modification and anticancer activity of antimicrobial peptide A4K14-Citropin 1.1.

Huaxing Shen, Wei Cong, Nan Wang, 2023, Bioorganic & medicinal chemistry letters.

Design, synthesis and antitumor activity of Ascaphin-8 derived stapled peptides based on halogen–sulfhydryl click chemical reactions

N. Zhang, Honggang Hu, Huaxing Shen, 2023, RSC advances.

Stapled Peptides Targeting SARS-CoV-2 Spike Protein HR1 Inhibit the Fusion of Virus to Its Cell Receptor.

Xiang Li, Honggang Hu, Yan Zou, 2021, Journal of medicinal chemistry.